Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

9.20USD
17 Aug 2018
Change (% chg)

$-0.02 (-0.22%)
Prev Close
$9.22
Open
$9.18
Day's High
$9.31
Day's Low
$9.13
Volume
22,126
Avg. Vol
79,872
52-wk High
$12.00
52-wk Low
$2.81

Chart for

About

Aeglea BioTherapeutics, Inc. is a biotechnology company, which is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism (IEM) and cancer. The Company's product pipeline includes AEB1102, AEB3103, AEB2109 and AEB4104. Its lead product candidate, AEB1102,... (more)

Overall

Beta: --
Market Cap(Mil.): $87.77
Shares Outstanding(Mil.): 16.45
Dividend: --
Yield (%): --

Financials

  AGLE.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.82 -- --
ROI: -36.00 1.78 14.61
ROE: -36.04 3.28 16.33

BRIEF-Aeglea Biotherapeutics Announces Proposed Public Offering

* AEGLEA BIOTHERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

17 Apr 2018

Earnings vs. Estimates